A team of clinical epidemiologists is designing an observational cohort study to evaluate the association between a newly approved biologic therapy for severe asthma and the subsequent risk of developing serious respiratory infections. The investigators are concerned about a specific variable: baseline pulmonary function (measured by FEV1). Patients with poorer baseline FEV1 are more likely to be prescribed the new biologic therapy and are also independently at a higher risk of developing serious respiratory infections, regardless of the treatment they receive.
Which of the following methodological techniques, if appropriately implemented during the design or analysis phase of the study, would effectively control for the confounding effect of baseline pulmonary function? (Select all that apply)
- Matching each patient receiving the new biologic therapy with a control patient who has a similar baseline FEV1Answer
- Restricting the study enrollment exclusively to patients who have a baseline FEV1 between 60% and 80% of predictedAnswer
- Adjusting for baseline FEV1 as an independent covariate in a multivariable regression modelAnswer
- DMasking the outcome assessors to the treatment group allocation of each participant
- EReporting stratum-specific relative risks to highlight differing magnitudes of the biologic's effect across baseline FEV1 categories